Histogenics Corp.
(NASDAQ : HSGX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.32%198.241.3%$525.29m
GILDGilead Sciences, Inc.
1.43%66.900.9%$355.52m
ALXNAlexion Pharmaceuticals, Inc.
0.91%106.632.0%$330.75m
ILMNIllumina, Inc.
0.68%307.283.5%$318.07m
BIIBBiogen Inc.
2.43%241.351.3%$313.50m
CELGCelgene Corporation
0.50%99.451.3%$296.05m
VRTXVertex Pharmaceuticals Incorporated
1.66%179.061.9%$177.64m
AAgilent Technologies, Inc.
0.65%78.581.6%$177.01m
REGNRegeneron Pharmaceuticals, Inc.
3.11%295.052.6%$171.55m
SRPTSarepta Therapeutics, Inc.
-2.65%83.1014.6%$141.40m
EXASExact Sciences Corporation
-0.11%103.2924.1%$138.60m
ACADACADIA Pharmaceuticals Inc.
-0.94%41.2913.9%$124.27m
INCYIncyte Corporation
2.62%80.172.5%$87.44m
ALDRAlder Biopharmaceuticals, Inc.
0.05%18.6710.2%$76.45m
BMRNBioMarin Pharmaceutical Inc.
-0.45%75.664.3%$75.28m

Company Profile

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.